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Letters to the Editor3. In a neonatal case with a common
chamber located inferiorly, a suffi-
ciently large flap cannot be created
to completely cover the atrial com-
munication.
4. Insufficient anastomosis between
the intima of common chamber
and the endocardium in the LA
may cause a coronary artery steal.
5. Late postoperative atrial arrhyth-
mia is unknown.
We believe that this new procedure
is applicable even in neonatal cases
with TAPVC drainage into the CS.
However, a long observation period
will be required for those patients
who undergo this new procedure.
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doi:10.1016/j.jtcvs.2009.10.055Reply to the Editor:
I thank Dr Nagashima and colleagues
for their insightful comments on our
new surgical technique for cardiac-
type total anomalous pulmonary ve-
nous drainage (TAPVD).1 Pulmonary
venous obstruction (PVO) is an inevi-
table, serious complication after the re-
pair of cardiac-type TAPVR by
conventional surgical techniques.2,3
Turbulent blood flow at the warped
pulmonary venous pathway through800 The Journal of Thoracic and Cthe coronary sinus2 or a narrow com-
munication between the pulmonary
venous channel and the left atrium3
may cause intimal proliferation fol-
lowed by PVO. Although the coronary
sinus is usually dilated in cardiac-type
TAPVD, it is by no means wide
enough to serve as the permanent pul-
monary venous pathway. In contrast,
the posterior wall transference tech-
nique1 can create laminar pulmonary
venous blood flow through a wide
and straight communication into the
left atrium.
With the posterior wall transference
technique, the common wall between
the left atrium and the pulmonary ve-
nous chamber is cut out as a tongue-
like flap. It is also important not to cut
the pulmonary venous orifice to avoid
postoperative PVO. Ordinarily, it
should be possible to incise the
posterior left atrial wall while preserv-
ing the pulmonary venous orifices,
because the pulmonary venous orifices
are clearly visible during the procedure.
The roof of the coronary sinus and
posterior wall of the left atrium is ap-
plied to a new atrial septum with the
posterior wall transference technique.
To avoid damage to the atrioventricu-
lar node, the roof of the coronary sinus
should not be cut longitudinally along
its caudal edge but along little to the
middle. The right atrial portion of the
roof of the coronary sinus can then
be safely anastomosed to the floor of
the coronary sinus far away from the
atrioventricular node.
The neonatal posterior left atrial
wall is certainly a rather small area. In-
deed, a small posterior left atrial wall
flap would be insufficient to com-
pletely fill the atrial septal defect. A
supplementary autologous pericardial
patch is necessary in such cases. The
pericardial patch will not cause PVO,
because the patch is used to fill the re-
sidual atrial septal defect rather than
to construct the pulmonary venous
pathway. Furthermore, stenosis at the
junction of the common pulmonary
chamber with the coronary sinus or
within the coronary sinus is rare.4ardiovascular Surgery c March 2010PVO is not usually exacerbated during
the neonatal period in cardiac-type
TAPVD. The posterior wall transfer-
ence technique1 is easily performed in
infancy. Therefore, risky emergency
surgical intervention is unnecessary
for neonates without signs of PVO.
Nagashima and colleagues also
pointed out postoperative abnormal
coronary artery flow toward the
atrium. This excursive complication
does not arise from a deficiency of
the posterior wall transference tech-
nique. Mural coronary artery steal is
certainly avoidable by adequate firm
anastomosis of the atrial wall.
Three infants with cardiac type
TAPVD underwent repair by the pos-
terior wall transference technique at
our institution. Ages at the time of op-
eration were 2, 4, and 6 months. Body
weights ranged from 3.9 to 5.5 kg.
The follow-up period ranged from to
22 to 70 months. No arrhythmias
were seen on postoperative electrocar-
diography. Postoperative echocardio-
grams demonstrated a wide
pulmonary venous pathway without
stenosis. The posterior wall transfer-
ence technique for cardiac-type
TAPVD is a useful surgical option
without the complications of late
PVO and arrhythmias.
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IMPORTANCE OF BASELINE
COMPARISONS IN A CLINICAL
TRIAL
To the Editor:
We read with interest the study by
Hecht-Dolnik and associates in the Sep-
tember 2009 issue of the Journal, ‘‘He-
tastarch Increases the Risk of Bleeding
Complications in Patients After Off-
Pump Coronary Bypass Surgery: A
Randomized Clinical Trial.’’ In this ar-
ticle, they conclude that the intraopera-
tive administration of 1 L of hetastarch
was associated with an increase in post-
operative chest tube drainage and trans-
fusionofbloodproducts,which resulted
in early termination of the study.
Although we acknowledge the im-
portance of the clinical question the au-
thors have addressed, we have major
concerns regarding the equality of the
intervention and the control groups at
baseline and the method in which this
is reported. Although the authors claim
that there were no statistically signifi-
cant differences in baseline character-
istics between groups, Table 1
indicates the baseline international nor-
malized ratio (INR) in the hetastarch
group was 1.47 (2.12) whereas in the
albumin group baseline INR was 1.07
(0.10), values presented as mean (stan-
dard deviation). Although the mean
value between these 2 groups may not
be statistically different, it is mislead-
ing to claim baseline equivalence be-
tween the groups. The upper limit of
INR is typically quoted at 1.3, indicat-
ing the mean INR in the hetastarch
group is abnormal and in the albumin
group mean INR is normal. Further-
more, the large standard deviation in
baseline INR in the hetastarch group
can only be explained by the presence
of one or more outliers with markedly
abnormal baseline value. In contrast,
the standard deviation for INR of theThe Journalalbumin group is small (0.10), indicat-
ing a typically normal distribution. We
would suggest that this method of re-
porting baseline INR is potentiallymis-
leading. Presenting the proportion of
patients in each group with abnormal
INR at baseline would be substantially
more informative to judge baseline
equivalence of the 2 groups.
This difference in baseline INR and,
by inference, bleeding risk is difficult to
explain in a trial whose group assign-
ment was by random allocation. How-
ever, in a study whose primary
outcomewas transfusion of bloodprod-
ucts, understanding a difference of this
nature is vitally important to interpreta-
tion of the results, particularly where
transfusion practicewas neither blinded
nor protocol guided, as in this study.
We believe this highlights the im-
portance of using the appropriate
method of data presentation to describe
baseline characteristics in a clinical
trial as well as the potential pitfall of re-
lying on P values greater than .05 to in-
dicate baseline equivalence of groups
rather than clinical interpretation for
the potential influence of an observed
difference on the outcome of interest.
DavidMcIlroy,MD,MClinEpi, FANZCA
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doi:10.1016/j.jtcvs.2009.10.058Reply to the Editor:
We extend our thanks to Drs McIlroy
and Nishanian for their careful reading
of our article. Their concerns would
be well placed if the average baseline
international normalized ratio (INR) in
the hetastarch group were 1.47. Their
comment led us to review the project
source data. That review revealed
several transcription errors in which
the decimal place in the INR was mis-
placed. The average baseline INR after
correction of those transcription errorsof Thoracic and Cardiovascular Surgeis 1.06 (standard deviation ¼ 0.11).
This correction thus reverses the direc-
tion of the difference between the
hetastarch and albumin groups in the
average INR from that presented in
the initial article. The statistical signifi-
cance of the difference in average INR
between the albumin and hetastarch
groups becomes even weaker, remain-
ing not statistically significant (Student
t ¼ 0.77; P ¼ .44, not significant).
We then investigated how many
cases in each group had a baseline
INR above the 1.30 threshold, as Drs
McIlroy and Nishanian suggested.
That threshold is crossed by 2 members
(2.6%) of the albumin group and 3
members (3.8%) of the hetastarch
group. The difference in the proportion
in each groupwith an INRabove the 1.3
threshold is not statistically significant
(Fisher exact test¼ 1.0, not significant).
This corrected finding supports
treating the intervention and control
groups in this study as equivalent. We
apologize for any misunderstandings
caused by this inaccuracy in the initial
reported statistics summarizing and
comparing baseline characteristics.
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THE TREATMENT OF
ANOMALOUS ORIGINS OF
RIGHT OR LEFT
CORONARYARTERIES
ASSOCIATED WITH
AORTOPULMONARY
WINDOWS
To the Editor:
Aortopulmonary window (APW)
and anomalous right coronary artery
(RCA) originating from the pulmonaryry c Volume 139, Number 3 801
